Wordt geladen...
Recent advances of glucocorticoids in the treatment of Duchenne muscular dystrophy (Review)
Duchenne muscular dystrophy (DMD) is the most common degenerative neuromuscular disease. The incidence of DMD in live births is 1/3,600-1/6,000. Although glucocorticoid-dependent medication is the mainstay treatment option for DMD, a standard treatment regimen has yet to be determined. The present r...
Bewaard in:
| Gepubliceerd in: | Exp Ther Med |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
D.A. Spandidos
2021
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7967797/ https://ncbi.nlm.nih.gov/pubmed/33777191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2021.9875 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|